Praveen Kumar Reddy Nagireddy Selected Research

Triple Negative Breast Neoplasms

11/2020	9-PAN promotes tubulin- and ROS-mediated cell death in human triple-negative breast cancer cells.
10/2020	Tubulin- and ROS-dependent antiproliferative mechanism of a potent analogue of noscapine, N-propargyl noscapine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Praveen Kumar Reddy Nagireddy Research Topics

Disease

5	Neoplasms (Cancer) 01/2022 - 11/2019
3	Breast Neoplasms (Breast Cancer) 01/2022 - 11/2020
2	Triple Negative Breast Neoplasms 11/2020 - 10/2020
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 11/2019

Drug/Important Bio-Agent (IBA)

6	Noscapine (Narcotine)IBA 01/2022 - 11/2019
4	TubulinIBA 01/2022 - 11/2019
2	Antitussive Agents (Antitussives)FDA Link 01/2022 - 01/2021
2	AlkaloidsIBA 01/2022 - 01/2022
1	isoquinolineIBA 01/2022
1	phthalideIBA 01/2022
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	LatexIBA 01/2022
1	Docetaxel (Taxotere)FDA Link 01/2021
1	N-propargylIBA 10/2020
1	lissamine rhodamine B (sulforhodamine B)IBA 10/2020
1	Pharmaceutical PreparationsIBA 10/2020
1	Proteins (Proteins, Gene)FDA Link 11/2019

Therapy/Procedure

1	Therapeutics 01/2021